Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)
China · Delayed Price · Currency is CNY 17.96
+1.63 (9.98%)
Jun 18, 2026, 3:00 PM CST
SHA:600671 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 16.34 | 17.62 | 15.25 | -38.28 | -67.52 | -29.8 |
Depreciation & Amortization | 24.63 | 24.63 | 18.58 | 15.01 | 18.34 | 12.3 |
Other Amortization | 12.55 | 12.55 | 3.47 | 1.21 | 2.42 | 2.29 |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 0 | -0.33 | 0.09 | -0.04 |
Asset Writedown & Restructuring Costs | 0.69 | 0.69 | 0.83 | 6.01 | 17.76 | 2.92 |
Loss (Gain) From Sale of Investments | 1.71 | 1.71 | -0.03 | 0.53 | -0.96 | - |
Provision & Write-off of Bad Debts | 1.96 | 1.96 | 2.29 | -2.99 | 4.99 | 4.05 |
Other Operating Activities | -10.86 | -2.36 | 13.25 | 11.5 | 14.05 | 9.81 |
Change in Accounts Receivable | -50.12 | -50.12 | -64.08 | -6.41 | 43.19 | -27.41 |
Change in Inventory | 13.14 | 13.14 | -9.38 | 4.87 | -1.15 | 11.79 |
Change in Accounts Payable | -7.14 | -7.14 | -16.42 | -11.57 | -49.65 | -13.93 |
Change in Other Net Operating Assets | - | - | - | - | -2.13 | 2.32 |
Operating Cash Flow | 2.01 | 11.79 | -36.67 | -20.43 | -19.37 | -26.42 |
Capital Expenditures | -30.08 | -31.18 | -20.55 | -8.96 | -3.52 | -4.71 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0 | 0.17 | 0 | 0.34 |
Cash Acquisitions | - | - | -6.31 | - | -2.2 | 0.22 |
Divestitures | - | - | - | -0.04 | -0.08 | - |
Investment in Securities | 0 | 0 | - | - | - | - |
Other Investing Activities | 3.5 | - | - | - | - | - |
Investing Cash Flow | -26.56 | -31.15 | -26.86 | -8.83 | -5.8 | -4.16 |
Short-Term Debt Issued | - | 162.14 | 149.71 | 102.45 | 110.45 | 181.2 |
Long-Term Debt Issued | - | - | 81.47 | 59.45 | 55.65 | - |
Total Debt Issued | 205.09 | 162.14 | 231.18 | 161.9 | 166.1 | 181.2 |
Short-Term Debt Repaid | - | -146.75 | -205.75 | -162.04 | -112.55 | -145.83 |
Long-Term Debt Repaid | - | -9.01 | -8.33 | -4.78 | -60.27 | -44.09 |
Total Debt Repaid | -162.02 | -155.76 | -214.09 | -166.82 | -172.82 | -189.92 |
Net Debt Issued (Repaid) | 43.07 | 6.38 | 17.09 | -4.92 | -6.72 | -8.72 |
Issuance of Common Stock | 1.74 | 1.77 | 7.43 | 90 | 0.27 | - |
Common Dividends Paid | -6.58 | -6.5 | -8.58 | -6.67 | -4.78 | -6.71 |
Other Financing Activities | -3.7 | -3.48 | -2.9 | 6.41 | 67.29 | 49.94 |
Financing Cash Flow | 34.53 | -1.83 | 13.04 | 84.83 | 56.06 | 34.52 |
Net Cash Flow | 9.98 | -21.19 | -50.5 | 55.57 | 30.89 | 3.94 |
Free Cash Flow | -28.07 | -19.39 | -57.23 | -29.38 | -22.89 | -31.13 |
Free Cash Flow Margin | -13.77% | -9.16% | -26.34% | -24.13% | -21.02% | -21.17% |
Free Cash Flow Per Share | -0.23 | -0.16 | -0.47 | -0.24 | -0.19 | -0.25 |
Cash Income Tax Paid | 24.36 | 24.36 | 13.72 | 6.13 | 2.99 | 8.25 |
Levered Free Cash Flow | -28.24 | -48.41 | -25.67 | -12.72 | 37.87 | 42.11 |
Unlevered Free Cash Flow | -23.6 | -43.91 | -22.19 | -8.23 | 42.5 | 46.71 |
Change in Working Capital | -45.03 | -45.03 | -90.32 | -13.1 | -8.55 | -27.96 |